Different suppressor genes and oncogenes have been found among different histopathological subgroups of patients (i.e., the PTEN mutation associated with endometrioid endometrial carcinoma and the p53 mutation in serous endometrial carcinoma [63]). This evidence concerns the gene PTEN and endometrial endometrioid carcinoma.